“Your baby has a genetic disease.” It’s one of the most terrifying things that new parents can hear. Yet it frequently turns out not to be true because, while newborn screening is extremely accurate for many common conditions, screening accuracy rates for rare — even fatal — conditions can be abysmal, according to genetics specialists.
The New England Journal of Medicine published a paper Nov. 3 that described how children with high-risk Hodgkin lymphoma responded to a targeted therapy for the disease that has been effective in adults.
Steven E. Lipshultz, MD, the A. Conger Goodyear Professor and Chair of pediatrics, is co-author on a new paper that validates the long-term efficacy and safety of metabolic and bariatric surgery (MBS) for treatment of adolescent obesity.
Nineteen faculty members with clinical and research experience have joined the departments of Biomedical Informatics, Family Medicine, Medicine, Orthopaedics, Pathology and Anatomical Sciences, Pediatrics, Physiology and Biophysics, and Psychiatry.
